Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/13/1133   
Active ingredient: Maribavir
Indication: Treatment of cytomegalovirus disease in patients with impaired cell mediated immunity
Sponsor: Shire Pharmaceuticals Ireland Limited
Block 2-3 Miesian Plaza, 50-58 Baggot Street Lower, Dublin 2, Ireland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2013 Orphan designation EMA/OD/013/13 (2013)3668 of 7/06/2013
19/02/2016 Change of name and/or address of sponsor
18/03/2016 Transfer of orphan designation EMA/OD/013/13/T/01 (2016)1714 of 15/03/2016
6/11/2017 Change of name and/or address of sponsor